
Melanotan II (10 mg Vial)
Melanotan II is a synthetic analog of α-melanocyte-stimulating hormone studied for its ability to increase skin pigmentation and noted for inducing erectile activity as a side effect. Early human trials identified effective daily doses in the range of 1–2 mg for tanning, with conservative protocols starting lower to minimize side effects such as nausea and flushing. This educational protocol presents a once-daily subcutaneous titration approach using practical dilution for clear insulin-syringe measurements.
- Dose
- 0.25–0.5 mg per injection
- Frequency
- 3–7 times weekly
- Timing
- Any time of day
- Duration
- Until desired pigmentation achieved
Melanocortin receptor agonist. Promotes tanning. Start low to assess tolerance.
| Week / Phase | Daily Dose | Units (per injection) (mL) |
|---|---|---|
| Week 1 | 250 mcg (0.25 mg) | 7.5 units (0.075 mL) |
| Week 2 | 500 mcg (0.5 mg) | 15 units (0.15 mL) |
| Week 3 | 750 mcg (0.75 mg) | 22.5 units (0.225 mL) |
| Weeks 4–8 | 1000 mcg (1 mg) | 30 units (0.30 mL) |
| Maintenance<br>(after Week 8) | 500–1000 mcg<br>(1–2× weekly) | 15–30 units<br>(0.15–0.30 mL) |
- •Peptide Vials (Melanotan II, 10 mg each):
- •Insulin Syringes (U-100, 1 mL):
- •Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.
- •Alcohol Swabs: One for the vial stopper + one for the injection site each day.
PubMed — Dorr RT et al. (1996)
Dorr RT et al. (1996)**
View sourceInternational Peptide Society — Melanotan II Monograph
Melanotan II Monograph**
View sourceDermNet NZ — Melanotan II Information for Patients
Melanotan II Information for Patients**
View sourcePubMed — Nelson ME et al. (2012)
Nelson ME et al. (2012)**
View sourceRxList — Melanotan-II Uses, Side Effects and Dosing
Melanotan-II Uses, Side Effects and Dosing**
View sourceCell Sciences Inc. — Product Data Sheet
Product Data Sheet**
View sourceMedlinePlus — Subcutaneous Injections
Subcutaneous Injections**
View sourceNCBI Bookshelf — Administration of Parenteral Medications
Administration of Parenteral Medications**
View sourceCDC — Vaccine Administration Guidelines
Vaccine Administration Guidelines**
View sourceNCBI Bookshelf — Best Practices for Injection Safety
Best Practices for Injection Safety**
View source
Educational content adapted from peptidedosages.com. Not medical advice.